首页> 美国卫生研究院文献>Journal of Medical Case Reports >Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report
【2h】

Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report

机译:口服利巴韦林在免疫功能正常的患者中对呼吸道合胞病毒引起的急性呼吸窘迫综合征的可能治疗作用:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHuman respiratory syncytial virus usually causes self-limiting upper respiratory infection and occasionally causes pneumonia in immunocompromised hosts. Respiratory syncytial virus-induced severe pneumonia or acute respiratory distress syndrome in immunocompetent adults has been rarely described. Unfortunately, optimal treatment has not been established for this potentially fatal condition. We report a case of respiratory syncytial virus-induced acute respiratory distress syndrome occurring in a previously healthy man successfully treated with orally administered ribavirin.
机译:背景人类呼吸道合胞病毒通常引起自限性上呼吸道感染,并偶尔在免疫功能低下的宿主中引起肺炎。很少有人描述免疫功能正常的成年人中由呼吸道合胞病毒引起的严重肺炎或急性呼吸窘迫综合征。不幸的是,尚未建立针对这种潜在致命疾病的最佳治疗方法。我们报告了一例呼吸道合胞病毒引起的急性呼吸窘迫综合征,该病例发生在先前健康的人中,口服口服利巴韦林已成功治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号